Clinical Trial

Examining the Effectiveness of Single-Limb Exercise Training for COPD Patients During Exacerbation Periods

Completed
View on ClinicalTrials.gov →
Summary
Resistance exercise applications during acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD) are employed to enhance functional capacity and prevent muscle atrophy by increasing muscle strength. Owing to the limited cardiorespiratory reserve of COPD patients, single-limb exercises are better tolerated compared to traditional bilateral exercises. A study conducted by Vogiatzis et al. (2009) indicated that single-leg exercises require lower ventilation and result in more efficient oxygen consumption than bilateral exercises. This physiological advantage may be effective in reducing muscle weakness by increasing exercise endurance in COPD patients with restricted respiratory capacity. The present study aims to demonstrate that single-limb resistance exercise is an effective rehabilitation method for increasing functional exercise capacity in patients during COPD exacerbations compared to a control group. Furthermore, the therapeutic effects of single-limb resistance exercises on dyspnea perception, fatigue, anxiety, and depression will be established. The study will also show that these exercises are both feasible and safe within rehabilitation protocols during the exacerbation period.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Completed 2026-07-19
notable Primary completion moved earlier: 2026-08-01 -> 2026-05-01 2026-07-19
minor Completion moved earlier: 2027-09-25 -> 2026-06-25 2026-07-19
Trial Details
NCT Number NCT07348003
Lead Sponsor Alper Kemal Gürbüz
Conditions Chronic Obstructive Airways Disease Exacerbated
Enrollment 30 participants
Start Date 2026-01-02
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-06-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-24